Can-Fite BioPharma Registration Statement Declared Effective
Ticker: CANF · Form: EFFECT · Filed: 2026-04-06T00:15:21-04:00
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
Related Tickers: CFBI
TL;DR
CFBI registration statement effective 4/3/26. SEC approved.
AI Summary
Can-Fite BioPharma Ltd. filed an EFFECT form on April 6, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-001089, relates to Act 33 and File No. 333-294760. The effectiveness date is noted as April 3, 2026.
Why It Matters
This filing signifies that Can-Fite BioPharma's securities offering has met SEC requirements and can now proceed. It's a crucial step for companies looking to raise capital through public markets.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming the effectiveness of a registration statement, not indicating new financial performance or operational changes.
Key Numbers
- 2026-04-03 — Effectiveness Date (The date the registration statement became effective.)
- 2026-04-06 — Filing Date (The date the filing was accepted by the SEC.)
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Filer
- 9999999995-26-001089 (dollar_amount) — SEC Accession Number
- 333-294760 (dollar_amount) — File Number
- 2026-04-06 (date) — Filing Acceptance Date
- 2026-04-03 (date) — Effectiveness Date
FAQ
What type of filing is this?
This is an EFFECT filing, which is a Notice of Effectiveness for a registration statement.
Who is the filer?
The filer is Can-Fite BioPharma Ltd.
What is the SEC Accession Number for this filing?
The SEC Accession Number is 9999999995-26-001089.
When did the registration statement become effective?
The registration statement became effective on April 3, 2026.
What is the File Number associated with this registration?
The File Number is 333-294760.
From the Filing
EDGAR Filing Documents for 9999999995-26-001089 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001089 Accepted 2026-04-06 00:15:21 Documents 1 Effectiveness Date 2026-04-03 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 593 Complete submission text file 9999999995-26-001089.txt 1715 Mailing Address 26 BEN GURION STREET RAMAT GAN L3 5257346 Business Address 26 BEN GURION STREET RAMAT GAN L3 5257346 972 39241114 Can-Fite BioPharma Ltd. (Filer) CIK : 0001536196 (see all company filings) EIN. : 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-294760 | Film No.: 26839472 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)